Below are the most recent publications written about "Carcinoma, Large Cell" by people in Profiles.
-
Young KA, Efiong E, Dove JT, Blansfield JA, Hunsinger MA, Wild JL, Shabahang MM, Facktor MA. External Validation of a Survival Nomogram for Non-Small Cell Lung Cancer Using the National Cancer Database. Ann Surg Oncol. 2017 Jun; 24(6):1459-1464.
-
Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, Kavadi V, Garces YI, Narayan S, Iyengar P, Robinson C, Wynn RB, Koprowski C, Meng J, Beitler J, Gaur R, Curran W, Choy H. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015 Feb; 16(2):187-99.
-
Guckenberger M, Kestin LL, Hope AJ, Belderbos J, Werner-Wasik M, Yan D, Sonke JJ, Bissonnette JP, Wilbert J, Xiao Y, Grills IS. Is there a lower limit of pretreatment pulmonary function for safe and effective stereotactic body radiotherapy for early-stage non-small cell lung cancer? J Thorac Oncol. 2012 Mar; 7(3):542-51.
-
Campling BG, Collins BN, Algazy KM, Schnoll RA, Lam M. Spontaneous smoking cessation before lung cancer diagnosis. J Thorac Oncol. 2011 Mar; 6(3):517-24.
-
Tsimpas A, Post NH, Moshel Y, Frempong-Boadu AK. Large cell neuroendocrine carcinoma of the lung metastatic to the cauda equina. Spine J. 2010 Jun; 10(6):e1-5.
-
Linkous A, Geng L, Lyshchik A, Hallahan DE, Yazlovitskaya EM. Cytosolic phospholipase A2: targeting cancer through the tumor vasculature. Clin Cancer Res. 2009 Mar 1; 15(5):1635-44.
-
Okamoto I, Kenyon LC, Emlet DR, Mori T, Sasaki J, Hirosako S, Ichikawa Y, Kishi H, Godwin AK, Yoshioka M, Suga M, Matsumoto M, Wong AJ. Expression of constitutively activated EGFRvIII in non-small cell lung cancer. Cancer Sci. 2003 Jan; 94(1):50-6.
-
Werner-Wasik M, Scott C, Cox JD, Sause WT, Byhardt RW, Asbell S, Russell A, Komaki R, Lee JS. Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival. Int J Radiat Oncol Biol Phys. 2000 Dec 1; 48(5):1475-82.
-
Werner-Wasik M, Scott C, Graham ML, Smith C, Byhardt RW, Roach M, Andras EJ. Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients. Int J Radiat Oncol Biol Phys. 1999 May 1; 44(2):327-31.